GLOBAL ANTI-AGING SERVICES & DEVICES MARKET FORECAST 2024-2032
世界のアンチエイジングサービス&デバイス市場予測 2024-2032年
Global Anti-aging Services & Devices Market by Age Group (18-34 Years Old, 35-50 Years Old, 51-64 Years Old, 65 Years or Older) Market by User Demographic (Male, Female) Market by Device Type (Professional Stand-alone Device, Direct-to-consumer Device) Market by Treatment (Anti-cellulite Treatment, Anti-wrinkle Treatment, Anti-pigmentation Treatment, Skin Resurfacing Treatment, Other Treatments) Market by Device (Exfoliation Device, Laser Device, Led/light Therapy Device, Microdermabrasion Device, Microneedling Device, Nano-current & Micro-current Device, Pulsed Light Device, Radiofrequency Device, Ultrasound Device, Other Devices) Market by End-user (Dermatology Clinics, Hospitals, Rejuvenation Centers, Home Use) by Geography
Report Overview Inkwood Researchでは世界の主要地域・国別の市場調査レポートも出版しています。各レポートの詳細についてはChosaReport.comまでお問合せください。
- 米国のアンチエイジングサービス&デバイス市場予測 2024-2032年
UNITED STATES ANTI-AGING SERVICES & DEVICES MARKET FORECAST 2024-2032 - 英国のアンチエイジングサービス&デバイス市場予測 2024-2032年
UNITED KINGDOM ANTI-AGING SERVICES & DEVICES MARKET FORECAST 2024-2032 - 韓国のアンチエイジングサービス&デバイス市場予測 2024-2032年
SOUTH KOREA ANTI-AGING SERVICES & DEVICES MARKET FORECAST 2024-2032
KEY FINDINGS
The global anti-aging services & devices market is expected to register a CAGR of 11.03% during the forecast period, 2024-2032. The market growth is attributed to the preventive approach and early adoption of anti-aging treatments among younger generations, the growing aging population, and the demand for minimally invasive and non-invasive treatments.
REPORT SYNOPSIS
REPORT SCOPE | DETAILS |
---|---|
Market Forecast Years | 2024-2032 |
Base Year | 2023 |
Market Historical Years | 2018-2022 |
Forecast Units | Revenue ($ Million) |
Segments Analyzed | Age Group, User Demographic, Device Type, Treatment, Device, and End-User |
Geographies Analyzed | North America, Europe, Asia-Pacific, and Rest of World |
Companies Analyzed | AbbVie, Candela Medical, Cutera Inc, Cynosure, Daewoong Pharmaceutical Co Ltd, ElEn SpA, Evolus Inc, Foreo, Galderma, Hugel Inc, Lumenis Ltd, Medytox Inc, Inmode Ltd, Merz Pharma, Revance Therapeutics Inc |